Table 1 Summary of patients with GIST
From: Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective
Patient | Age, Gender | Site | Presentation | Maximum diameter (mm) | CD117 & CD34 | Mitosis per HPF | Operation | Imatinib | Follow up (months) | Risk |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 66, F | Stomach | Mass | 70 | Positive | 10/50 | Wedge resection | No | 5, SD | High |
2 | 82, M | stomach | GI bleed | 60 | Positive | 2/50 | Wedge resection | No | 12, SD | Inter |
3 | 60, M | Stomach | GI bleed | 75 | Positive | 2/50 | Lap to open Wedge resection | No | 12, SD | Inter |
4 | 72, M | Stomach | Pain and distension | 110 | Positive | 300/50 | Debulking | Yes | 22, SD | High |
5 | 51, M | Stomach | Mass | 14.5 | Positive | None seen | Inoperable* | Yes | 3, PD | High |
6 | 61, F | ?Stomach/?extra-gasttrointestinal | Mass and distension | 260 | Positive | 8/50 | Excision and total hysterectomy | Yes # | 45, SD | High |
7 | 72, M | Stomach | Mass | 90 | Positive | 17/50 | Inoperable** | Yes | 6, Died of MI | High |
8 | 68, F | Stomach | GI bleed | 70 | Positive | 4/50 | Lap. wedge resection | No | 24, SD | Inter |
9 | 70, F | Oesophagus | Dysphagia | 20 | N/A | N/A | Not fit | No | 29, SD | N/A |
10 | 46, F | Stomach | GI bleed | 70 | Positive | 10/50 | Distal gastrectomy | No | 3 < SD | High |
11 | 77, F | Stomach | GI bleed | 80 | Positive | 34/50 | Distal gastrectomy | No | 9, Died | High |
12 | 47, M | Stomach | GI bleed | 50 | Not done | Not done | Wedge resection | No | 72, SD | N/A |
13 | 60, M | Duodenum | Incidental | 13 | N/A | N/A | Not fit | No | 14, SD | N/A |
14 | 74, F | Stomach | GI bleed | 40 | Positive | 2/50 | Lap. wedge resection | No | 9, SD | Low |
15 | 57, M | Duodenum | Cholangitis | 40 | Positive Negative | None | Duodenectomy | No | 62, SD | Low |
16 | 76, M | Stomach | GI bleed | 65 | Negative | 2/50 | No | Yes | 7, SD | Inter |